Meloxicam for skin cancer surgery pain
Treatments studied
Part of Cancer, Pain, Skin clinical trials.
This study tests if meloxicam, an anti-inflammatory painkiller, helps control pain after Mohs surgery for skin cancer. It aims to reduce the need for stronger opioid pain medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for Mohs surgery to remove skin cancer.
- You are not pregnant or planning to become pregnant.
- You do not have chronic liver disease (like hepatitis or cirrhosis).
- You do not have chronic kidney disease stage 3 or worse.
- You do not have a history of stomach ulcers, GI bleeding, or aspirin-sensitive asthma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-opioid pain medicine called suzetrigine compared to the usual pain relievers (like ibuprofen and acetaminophen) after skin cancer surgery on the head or neck. The goal is to see if it controls pain just as well with fewer side effects.
This study compares a new pain medication (suzetrigine) to a common pain reliever (Norco) for people recovering from Mohs micrographic surgery, a specialized procedure to remove skin cancer. The goal is to see if the new medication works better and is safer for post-surgery pain.
This study tests local anesthetics (numbing medicines) used during Mohs micrographic surgery, a specialized procedure for skin cancer. Researchers want to understand how well these numbing agents work and improve patient comfort during the procedure.
This study compares two common pain relievers, meloxicam and ibuprofen, after wisdom tooth removal. The goal is to find which one works better and is safer for managing pain after the procedure.
This trial tests whether a combination pain reliever (Maxigesic) works better than standard pain medicine after stomach cancer surgery. It aims to improve pain control and reduce the need for strong opioids.
This trial tests whether EMLA cream can reduce pain from injections needed to map lymph nodes for certain skin cancers. If you are scheduled for lymphoscintigraphy and sentinel lymph node biopsy, you may be eligible.
Hear when a new Postoperative Pain, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.